Status:
UNKNOWN
Study of Metabolic Changes in the Transformation Malignant Precancerous Skin Lesions
Lead Sponsor:
University Hospital, Bordeaux
Collaborating Sponsors:
Institut National de la Santé Et de la Recherche Médicale, France
Conditions:
Cutaneous Squamous Cell Carcinoma
Basal Cell Carcinomas
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Skin carcinomas are the most frequent cancers in the world, including basal cell carcinomas and cutaneous squamous cell carcinoma (cSCCs), with more than 60.000 new annual cases in France. Their incid...
Detailed Description
Although growing evidence indicates that bioenergetic metabolism plays an important role in the progression of tumorigenesis, little information is available on the contribution of reprogramming of en...
Eligibility Criteria
Inclusion
- Every patient with suspected lesion :
- AK,
- in situ cSCC,
- infiltrative cSSC
- cSCC with recurrent disease
- cSCC with cutaneous metastases.
- Patients 18 years of age or older,
- Patients with suspected AK or BCC lesions (in situ, infiltrating or metastatic),
- Patient able to sign a consent form,
- Patient affiliated with a Social Security system.
Exclusion
- Prior systemic treatment such as checkpoint inhibitors or chemotherapy.
- Patients with cSCC or AK localized on visible zone of the face or folds
Key Trial Info
Start Date :
February 28 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2022
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04389112
Start Date
February 28 2020
End Date
December 31 2022
Last Update
November 23 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Saint-André - CHU de Bordeaux
Bordeaux, France, 33000